Dale Broadrick - Jun 13, 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
10%+ Owner
Signature
/s/ Dale Broadrick
Stock symbol
BRTX
Transactions as of
Jun 13, 2022
Transactions value $
$5,097
Form type
4
Date filed
6/15/2022, 04:45 PM
Previous filing
Jun 13, 2022
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Purchase $5.1K +1.3K +0.45% $3.92 292K Jun 13, 2022 Direct F1
holding BRTX Common Stock 317K Jun 13, 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Warrant to acquire Common Stock 125 Jun 13, 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 125 Jun 13, 2022 Common Stock 125 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 Jun 13, 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 138 Jun 13, 2022 Common Stock 138 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 833 Jun 13, 2022 Common Stock 833 $120.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $3.8999 to $4.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
F2 Owned by Fleetco, Inc. of which reporting person is a 93% shareholder.